This inventor holds 1 USPTO granted patent. Top assignee: Adir Et Compagnie. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Ghanem Aasssi: Innovator in Dihydropyridine Compounds
Introduction
Ghanem Aasssi is a notable inventor based in Saint Cloud, France. He has made significant contributions to the field of chemistry, particularly through his work on 1,4-dihydropyridine compounds. His innovative approach has the potential to enhance the effectiveness of cancer treatments.
Latest Patents
Aasssi holds a patent for 1,4-dihydropyridine compounds, specifically 2,4-disubstituted 3-ethoxycarbonyl 5-methoxycarbonyl 6-methyl 1,4-dihydropyridines in their dextrorotatory form. These compounds are designed to potentiate the activity of cytotoxic agents and increase the sensitivity of tumor cells to antitumor agents. One of the disclosed compounds is d-2-{[2-(2-(N-p-nitrobenzylamino)ethoxy)ethoxy]methyl}-4-(2,3-dichlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine.
Career Highlights
Aasssi is associated with Adir Et Compagnie, where he continues to develop his research and innovations. His work has garnered attention for its potential applications in medical treatments, particularly in oncology.
Collaborations
Some of his notable coworkers include Jean-Louis Peglion and Alain Pierre. Their collaborative efforts contribute to the advancement of research in the field of medicinal chemistry.
Conclusion
Ghanem Aasssi's contributions to the development of 1,4-dihydropyridine compounds highlight his role as an innovator in the field of chemistry. His work has the potential to significantly impact cancer treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile